A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Taiho Oncology, Inc.
Taiho Oncology, Inc.
Eli Lilly and Company
Massachusetts General Hospital
Ossium Health, Inc.
Orca Biosystems, Inc.
Massachusetts General Hospital
Dana-Farber Cancer Institute
University of Southern California
Azienda USL Reggio Emilia - IRCCS
Cogent Biosciences, Inc.
University of Leipzig
Vincerx Pharma, Inc.
University Health Network, Toronto
AO GENERIUM